ORAGENICS, INC. Proceeds from Divestiture of Businesses
ORAGENICS, INC. (OGEN) reported Proceeds from Divestiture of Businesses of $1.45 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-16.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2018-02-16
- ORAGENICS, INC. proceeds from divestiture of businesses for the quarter ending 2016-12-31 was $200.00K.
- ORAGENICS, INC. proceeds from divestiture of businesses for the quarter ending 2016-09-30 was $0.00.
- ORAGENICS, INC. proceeds from divestiture of businesses for fiscal 2016 was $1.45M.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $200.00K derived: sum of 2 quarters · filed 2018-02-16 | $1.45M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.25M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | $1.25M 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |